nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—PTK6—Focal Adhesion—RELN—otosclerosis	0.03	0.0517	CbGpPWpGaD
Dasatinib—PDGFRA—Osteoblast Signaling—COL1A1—otosclerosis	0.0227	0.0392	CbGpPWpGaD
Dasatinib—FYN—Reelin signaling pathway—RELN—otosclerosis	0.0211	0.0363	CbGpPWpGaD
Dasatinib—SRMS—Focal Adhesion—RELN—otosclerosis	0.0208	0.0358	CbGpPWpGaD
Dasatinib—PDGFRB—Osteoblast Signaling—COL1A1—otosclerosis	0.0205	0.0353	CbGpPWpGaD
Dasatinib—ABL1—Lissencephaly gene (LIS1) in neuronal migration and development—RELN—otosclerosis	0.0197	0.0339	CbGpPWpGaD
Dasatinib—SIK2—connective tissue—otosclerosis	0.0184	0.0439	CbGeAlD
Dasatinib—TEC—tendon—otosclerosis	0.0183	0.0435	CbGeAlD
Dasatinib—TXK—Focal Adhesion—RELN—otosclerosis	0.0177	0.0305	CbGpPWpGaD
Dasatinib—TNK2—Focal Adhesion—RELN—otosclerosis	0.0172	0.0297	CbGpPWpGaD
Dasatinib—SRMS—connective tissue—otosclerosis	0.0167	0.0399	CbGeAlD
Dasatinib—PTK6—Focal Adhesion—COL1A1—otosclerosis	0.0161	0.0278	CbGpPWpGaD
Dasatinib—STAT5B—connective tissue—otosclerosis	0.0155	0.037	CbGeAlD
Dasatinib—CSF1R—Integrins in angiogenesis—COL1A1—otosclerosis	0.0144	0.0249	CbGpPWpGaD
Dasatinib—EPHB1—tendon—otosclerosis	0.0143	0.0341	CbGeAlD
Dasatinib—STAT5B—IL4-mediated signaling events—COL1A1—otosclerosis	0.0142	0.0244	CbGpPWpGaD
Dasatinib—LYN—connective tissue—otosclerosis	0.0126	0.0301	CbGeAlD
Dasatinib—BTK—connective tissue—otosclerosis	0.0124	0.0295	CbGeAlD
Dasatinib—MAPK14—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.012	0.0206	CbGpPWpGaD
Dasatinib—TESK1—connective tissue—otosclerosis	0.0115	0.0273	CbGeAlD
Dasatinib—SRMS—Focal Adhesion—COL1A1—otosclerosis	0.0112	0.0193	CbGpPWpGaD
Dasatinib—MAPK14—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0109	0.0188	CbGpPWpGaD
Dasatinib—CSK—connective tissue—otosclerosis	0.0105	0.025	CbGeAlD
Dasatinib—RIPK2—connective tissue—otosclerosis	0.00975	0.0232	CbGeAlD
Dasatinib—SIK3—tendon—otosclerosis	0.00959	0.0229	CbGeAlD
Dasatinib—SIK1—connective tissue—otosclerosis	0.00952	0.0227	CbGeAlD
Dasatinib—TXK—Focal Adhesion—COL1A1—otosclerosis	0.0095	0.0164	CbGpPWpGaD
Dasatinib—ERBB3—connective tissue—otosclerosis	0.00933	0.0222	CbGeAlD
Dasatinib—TNK2—Focal Adhesion—COL1A1—otosclerosis	0.00926	0.016	CbGpPWpGaD
Dasatinib—MAP3K2—connective tissue—otosclerosis	0.00924	0.022	CbGeAlD
Dasatinib—LCK—Inflammatory Response Pathway—COL1A1—otosclerosis	0.00893	0.0154	CbGpPWpGaD
Dasatinib—ZAK—tendon—otosclerosis	0.00891	0.0212	CbGeAlD
Dasatinib—MAPK14—connective tissue—otosclerosis	0.00869	0.0207	CbGeAlD
Dasatinib—HCK—Focal Adhesion—RELN—otosclerosis	0.00852	0.0147	CbGpPWpGaD
Dasatinib—BTK—tendon—otosclerosis	0.0085	0.0203	CbGeAlD
Dasatinib—SRC—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.00836	0.0144	CbGpPWpGaD
Dasatinib—PDGFRB—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.00835	0.0144	CbGpPWpGaD
Dasatinib—EPHB4—connective tissue—otosclerosis	0.00823	0.0196	CbGeAlD
Dasatinib—JAK2—connective tissue—otosclerosis	0.00818	0.0195	CbGeAlD
Dasatinib—FYN—connective tissue—otosclerosis	0.00806	0.0192	CbGeAlD
Dasatinib—TESK1—tendon—otosclerosis	0.00788	0.0188	CbGeAlD
Dasatinib—STK36—tendon—otosclerosis	0.00775	0.0185	CbGeAlD
Dasatinib—BLK—Focal Adhesion—RELN—otosclerosis	0.00772	0.0133	CbGpPWpGaD
Dasatinib—FGR—Focal Adhesion—RELN—otosclerosis	0.0077	0.0133	CbGpPWpGaD
Dasatinib—MAP2K5—Focal Adhesion—RELN—otosclerosis	0.00734	0.0126	CbGpPWpGaD
Dasatinib—YES1—connective tissue—otosclerosis	0.00728	0.0173	CbGeAlD
Dasatinib—STK35—tendon—otosclerosis	0.00727	0.0173	CbGeAlD
Dasatinib—CSK—tendon—otosclerosis	0.00722	0.0172	CbGeAlD
Dasatinib—PDGFRA—connective tissue—otosclerosis	0.00714	0.017	CbGeAlD
Dasatinib—HCK—tendon—otosclerosis	0.00713	0.017	CbGeAlD
Dasatinib—ABL2—tendon—otosclerosis	0.00708	0.0169	CbGeAlD
Dasatinib—SRC—connective tissue—otosclerosis	0.007	0.0167	CbGeAlD
Dasatinib—EPHB2—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00696	0.012	CbGpPWpGaD
Dasatinib—RIPK2—tendon—otosclerosis	0.0067	0.016	CbGeAlD
Dasatinib—SIK1—tendon—otosclerosis	0.00654	0.0156	CbGeAlD
Dasatinib—EPHA4—tendon—otosclerosis	0.00648	0.0154	CbGeAlD
Dasatinib—HCK—Glypican 1 network—TGFB1—otosclerosis	0.00638	0.011	CbGpPWpGaD
Dasatinib—CSF1R—connective tissue—otosclerosis	0.00629	0.015	CbGeAlD
Dasatinib—MAPK14—tendon—otosclerosis	0.00597	0.0142	CbGeAlD
Dasatinib—FGR—tendon—otosclerosis	0.00595	0.0142	CbGeAlD
Dasatinib—BLK—Glypican 1 network—TGFB1—otosclerosis	0.00578	0.00996	CbGpPWpGaD
Dasatinib—MAPK14—IL4-mediated signaling events—COL1A1—otosclerosis	0.00578	0.00996	CbGpPWpGaD
Dasatinib—FGR—Glypican 1 network—TGFB1—otosclerosis	0.00576	0.00993	CbGpPWpGaD
Dasatinib—KIT—connective tissue—otosclerosis	0.00571	0.0136	CbGeAlD
Dasatinib—JAK2—IL4-mediated signaling events—COL1A1—otosclerosis	0.00571	0.00983	CbGpPWpGaD
Dasatinib—EPHB4—tendon—otosclerosis	0.00566	0.0135	CbGeAlD
Dasatinib—JAK2—tendon—otosclerosis	0.00562	0.0134	CbGeAlD
Dasatinib—PDGFRB—connective tissue—otosclerosis	0.00557	0.0133	CbGeAlD
Dasatinib—EPHA2—tendon—otosclerosis	0.00555	0.0132	CbGeAlD
Dasatinib—FYN—tendon—otosclerosis	0.00554	0.0132	CbGeAlD
Dasatinib—MAP3K3—tendon—otosclerosis	0.00542	0.0129	CbGeAlD
Dasatinib—MAP4K5—tendon—otosclerosis	0.00542	0.0129	CbGeAlD
Dasatinib—PDGFRA—Focal Adhesion—RELN—otosclerosis	0.00525	0.00905	CbGpPWpGaD
Dasatinib—EPHB6—tendon—otosclerosis	0.00518	0.0123	CbGeAlD
Dasatinib—CSF1R—Differentiation Pathway—TGFB1—otosclerosis	0.00509	0.00877	CbGpPWpGaD
Dasatinib—ZAK—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00505	0.0087	CbGpPWpGaD
Dasatinib—YES1—tendon—otosclerosis	0.005	0.0119	CbGeAlD
Dasatinib—ABL1—connective tissue—otosclerosis	0.00497	0.0118	CbGeAlD
Dasatinib—PDGFRA—tendon—otosclerosis	0.00491	0.0117	CbGeAlD
Dasatinib—STAT5B—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00485	0.00836	CbGpPWpGaD
Dasatinib—PDGFRB—Focal Adhesion—RELN—otosclerosis	0.00473	0.00815	CbGpPWpGaD
Dasatinib—YES1—Glypican 1 network—TGFB1—otosclerosis	0.00465	0.00801	CbGpPWpGaD
Dasatinib—HCK—Focal Adhesion—COL1A1—otosclerosis	0.00458	0.00789	CbGpPWpGaD
Dasatinib—FYN—Focal Adhesion—RELN—otosclerosis	0.00456	0.00786	CbGpPWpGaD
Dasatinib—MYT1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00456	0.00785	CbGpPWpGaD
Dasatinib—SIK1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00443	0.00763	CbGpPWpGaD
Dasatinib—MAP2K5—tendon—otosclerosis	0.00443	0.0106	CbGeAlD
Dasatinib—SRC—Integrins in angiogenesis—COL1A1—otosclerosis	0.00437	0.00753	CbGpPWpGaD
Dasatinib—CSF1R—tendon—otosclerosis	0.00432	0.0103	CbGeAlD
Dasatinib—CYP1B1—connective tissue—otosclerosis	0.00421	0.01	CbGeAlD
Dasatinib—BLK—Focal Adhesion—COL1A1—otosclerosis	0.00415	0.00715	CbGpPWpGaD
Dasatinib—FGR—Focal Adhesion—COL1A1—otosclerosis	0.00414	0.00713	CbGpPWpGaD
Dasatinib—MAP2K5—Focal Adhesion—COL1A1—otosclerosis	0.00395	0.0068	CbGpPWpGaD
Dasatinib—STAT5B—Endochondral Ossification—TGFB1—otosclerosis	0.00392	0.00675	CbGpPWpGaD
Dasatinib—HCK—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00384	0.00662	CbGpPWpGaD
Dasatinib—PDGFRB—tendon—otosclerosis	0.00383	0.00913	CbGeAlD
Dasatinib—MAPK14—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00379	0.00653	CbGpPWpGaD
Dasatinib—PKMYT1—Cell Cycle—TGFB1—otosclerosis	0.00356	0.00613	CbGpPWpGaD
Dasatinib—LYN—Glypican 1 network—TGFB1—otosclerosis	0.00347	0.00598	CbGpPWpGaD
Dasatinib—ABL1—tendon—otosclerosis	0.00342	0.00814	CbGeAlD
Dasatinib—FYN—Glypican 1 network—TGFB1—otosclerosis	0.00342	0.00588	CbGpPWpGaD
Dasatinib—SRC—Focal Adhesion—RELN—otosclerosis	0.00336	0.00579	CbGpPWpGaD
Dasatinib—JAK2—IL27-mediated signaling events—TGFB1—otosclerosis	0.00325	0.00559	CbGpPWpGaD
Dasatinib—YES1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00305	0.00526	CbGpPWpGaD
Dasatinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00302	0.0052	CbGpPWpGaD
Dasatinib—SRC—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.0029	0.005	CbGpPWpGaD
Dasatinib—CYP1B1—tendon—otosclerosis	0.00289	0.00689	CbGeAlD
Dasatinib—LCK—Glypican 1 network—TGFB1—otosclerosis	0.00284	0.0049	CbGpPWpGaD
Dasatinib—PDGFRA—Focal Adhesion—COL1A1—otosclerosis	0.00282	0.00486	CbGpPWpGaD
Dasatinib—EPHA4—Spinal Cord Injury—TGFB1—otosclerosis	0.00278	0.00479	CbGpPWpGaD
Dasatinib—KIT—Differentiation Pathway—TGFB1—otosclerosis	0.00254	0.00438	CbGpPWpGaD
Dasatinib—LIMK2—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00254	0.00438	CbGpPWpGaD
Dasatinib—PDGFRB—Focal Adhesion—COL1A1—otosclerosis	0.00254	0.00438	CbGpPWpGaD
Dasatinib—SRC—Glypican 1 network—TGFB1—otosclerosis	0.00252	0.00434	CbGpPWpGaD
Dasatinib—EPHA3—NRF2 pathway—TGFB1—otosclerosis	0.00246	0.00424	CbGpPWpGaD
Dasatinib—FYN—Focal Adhesion—COL1A1—otosclerosis	0.00245	0.00422	CbGpPWpGaD
Dasatinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00241	0.00416	CbGpPWpGaD
Dasatinib—KIT—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00235	0.00405	CbGpPWpGaD
Dasatinib—FYN—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00224	0.00386	CbGpPWpGaD
Dasatinib—RIPK2—TCR Signaling Pathway—TGFB1—otosclerosis	0.00223	0.00384	CbGpPWpGaD
Dasatinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00222	0.00383	CbGpPWpGaD
Dasatinib—STAT5B—Adipogenesis—TGFB1—otosclerosis	0.00222	0.00383	CbGpPWpGaD
Dasatinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00215	0.00371	CbGpPWpGaD
Dasatinib—JAK2—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00213	0.00367	CbGpPWpGaD
Dasatinib—LYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00209	0.0036	CbGpPWpGaD
Dasatinib—FYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00206	0.00354	CbGpPWpGaD
Dasatinib—JAK2—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00196	0.00337	CbGpPWpGaD
Dasatinib—SRC—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00194	0.00334	CbGpPWpGaD
Dasatinib—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00192	0.0033	CbGpPWpGaD
Dasatinib—EPHA2—NRF2 pathway—TGFB1—otosclerosis	0.00191	0.00329	CbGpPWpGaD
Dasatinib—MAP3K2—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00187	0.00322	CbGpPWpGaD
Dasatinib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00186	0.0032	CbGpPWpGaD
Dasatinib—SRC—Focal Adhesion—COL1A1—otosclerosis	0.00181	0.00311	CbGpPWpGaD
Dasatinib—MAPK14—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00181	0.00311	CbGpPWpGaD
Dasatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00172	0.00295	CbGpPWpGaD
Dasatinib—SRC—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00165	0.00285	CbGpPWpGaD
Dasatinib—PDGFRA—Allograft Rejection—TGFB1—otosclerosis	0.00162	0.00278	CbGpPWpGaD
Dasatinib—ABL1—Regulation of Telomerase—TGFB1—otosclerosis	0.0016	0.00276	CbGpPWpGaD
Dasatinib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00159	0.00275	CbGpPWpGaD
Dasatinib—EPHB1—Developmental Biology—TGFB1—otosclerosis	0.00154	0.00265	CbGpPWpGaD
Dasatinib—SRC—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00152	0.00261	CbGpPWpGaD
Dasatinib—FYN—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—otosclerosis	0.00151	0.0026	CbGpPWpGaD
Dasatinib—CSK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.0015	0.00259	CbGpPWpGaD
Dasatinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00129	0.00222	CbGpPWpGaD
Dasatinib—FYN—TCR Signaling Pathway—TGFB1—otosclerosis	0.00126	0.00218	CbGpPWpGaD
Dasatinib—MAP2K5—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00124	0.00213	CbGpPWpGaD
Dasatinib—MAPK14—TCR Signaling Pathway—TGFB1—otosclerosis	0.00122	0.0021	CbGpPWpGaD
Dasatinib—MAPK14—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.0012	0.00206	CbGpPWpGaD
Dasatinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00118	0.00203	CbGpPWpGaD
Dasatinib—ABL1—Cell Cycle—TGFB1—otosclerosis	0.00116	0.00199	CbGpPWpGaD
Dasatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.0011	0.00189	CbGpPWpGaD
Dasatinib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00108	0.00185	CbGpPWpGaD
Dasatinib—EPHB3—Developmental Biology—TGFB1—otosclerosis	0.00104	0.00179	CbGpPWpGaD
Dasatinib—EPHA3—Developmental Biology—TGFB1—otosclerosis	0.000928	0.0016	CbGpPWpGaD
Dasatinib—ABL2—Developmental Biology—TGFB1—otosclerosis	0.000928	0.0016	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—TGFB1—otosclerosis	0.000928	0.0016	CbGpPWpGaD
Dasatinib—MAPK14—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000896	0.00154	CbGpPWpGaD
Dasatinib—EPHA8—Developmental Biology—TGFB1—otosclerosis	0.000895	0.00154	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—TGFB1—otosclerosis	0.000885	0.00152	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—TGFB1—otosclerosis	0.000885	0.00152	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—TGFB1—otosclerosis	0.000885	0.00152	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—TGFB1—otosclerosis	0.000857	0.00148	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—TGFB1—otosclerosis	0.000832	0.00143	CbGpPWpGaD
Dasatinib—SRC—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.000824	0.00142	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000798	0.00137	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000796	0.00137	CbGpPWpGaD
Dasatinib—CSK—Hemostasis—TGFB1—otosclerosis	0.000774	0.00133	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.000753	0.0013	CbGpPWpGaD
Dasatinib—MAPK14—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000739	0.00127	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—TGFB1—otosclerosis	0.000721	0.00124	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.0007	0.00121	CbGpPWpGaD
Dasatinib—SRC—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.000686	0.00118	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000667	0.00115	CbGpPWpGaD
Dasatinib—LYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000626	0.00108	CbGpPWpGaD
Dasatinib—FYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000616	0.00106	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TGFB1—otosclerosis	0.000612	0.00105	CbGpPWpGaD
Dasatinib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000594	0.00102	CbGpPWpGaD
Dasatinib—JAK2—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000586	0.00101	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—TGFB1—otosclerosis	0.000536	0.000924	CbGpPWpGaD
Dasatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000513	0.000884	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000511	0.00088	CbGpPWpGaD
Dasatinib—SRC—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000454	0.000783	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TGFB1—otosclerosis	0.000441	0.00076	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—TGFB1—otosclerosis	0.000433	0.000746	CbGpPWpGaD
Dasatinib—CSK—Disease—TGFB1—otosclerosis	0.000375	0.000645	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—TGFB1—otosclerosis	0.000372	0.000641	CbGpPWpGaD
Dasatinib—STAT5B—Disease—TGFB1—otosclerosis	0.000363	0.000625	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TGFB1—otosclerosis	0.000329	0.000567	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TGFB1—otosclerosis	0.000327	0.000564	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TGFB1—otosclerosis	0.000324	0.000558	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—TGFB1—otosclerosis	0.000323	0.000556	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—TGFB1—otosclerosis	0.000321	0.000553	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—TGFB1—otosclerosis	0.000318	0.000547	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TGFB1—otosclerosis	0.000312	0.000537	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TGFB1—otosclerosis	0.000308	0.00053	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—TGFB1—otosclerosis	0.000306	0.000527	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000302	0.00052	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—TGFB1—otosclerosis	0.000302	0.00052	CbGpPWpGaD
Dasatinib—HCK—Disease—TGFB1—otosclerosis	0.000287	0.000495	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TGFB1—otosclerosis	0.000265	0.000456	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TGFB1—otosclerosis	0.000262	0.000452	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TGFB1—otosclerosis	0.000254	0.000438	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TGFB1—otosclerosis	0.000239	0.000411	CbGpPWpGaD
Dasatinib—ERBB3—Disease—TGFB1—otosclerosis	0.000239	0.000411	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TGFB1—otosclerosis	0.000234	0.000403	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—otosclerosis	0.00019	0.000327	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—otosclerosis	0.000187	0.000322	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—otosclerosis	0.000177	0.000305	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—otosclerosis	0.000173	0.000299	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—otosclerosis	0.000167	0.000288	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—otosclerosis	0.00016	0.000275	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—otosclerosis	0.000154	0.000265	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—otosclerosis	0.000147	0.000253	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—otosclerosis	0.000146	0.000252	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—otosclerosis	0.000131	0.000226	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—otosclerosis	0.000128	0.000221	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—otosclerosis	0.000124	0.000214	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—otosclerosis	0.000113	0.000195	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—otosclerosis	0.000112	0.000193	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—otosclerosis	0.000109	0.000188	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—otosclerosis	0.000108	0.000186	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—otosclerosis	0.000104	0.000179	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—otosclerosis	0.000102	0.000176	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—otosclerosis	8.97e-05	0.000155	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—otosclerosis	7.94e-05	0.000137	CbGpPWpGaD
